<DOC>
	<DOCNO>NCT00238537</DOCNO>
	<brief_summary>To determine whether extent ischemic penumbra apparent perfusion-diffusion MRI use identify patient would respond positively safely tissue plasminogen activator ( tPA ) beyond 3 hour post-stroke .</brief_summary>
	<brief_title>Echoplanar Imaging Thrombolysis Evaluation Trial ( EPITHET )</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Patients present : acute hemispheric stroke within 36 hour onset , least moderate limb weakness , National Institute Health Stroke Scale ( NIHSS ) score &gt; 4 , prestroke modify Rankin Scale ( MRS ) score 0 2 able undergo CT MRI , eligible study . Females pregnant breastfeeding , person CTverified hemorrhagic stroke , major ischemia ( &gt; 33 % middle cerebral artery ( MCA ) territory infarcted ) , subarachnoid hemorrhage , arteriovenous malformation , aneurysm , intracranial neoplasm terminal pose risk hemorrhage , comatose severely obtunded fix eye deviation complete hemiplegia , another stroke within past 6 week , seizure prior administration study drug , active peptic ulceration , bleed diatheses , previous intracerebral hemorrhage , blood pressure &gt; 185/110 , major surgery trauma within past 30 day , contraindication tPA presume septic embolus myocardial infarction within past 30 day blood glucose value &lt; 2.8 &gt; 22.0 mmol/L , pacemaker , aneurysm clip , implanted device , claustrophobia , contraindication MRI , decrease consciousness , rapid clinical improvement , confound neurological condition ( e.g . dementia ) , lifethreatening illness , participate another clinical trial , exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Thrombolysis</keyword>
	<keyword>MRI</keyword>
	<keyword>Echoplanar</keyword>
	<keyword>Penumbra</keyword>
</DOC>